74%
de los inversores minoristas pierde dinero cuando opera CFDs con este proveedor.
Invertir conlleva riesgos y no es adecuado para todos los inversores. Los CFDs son instrumentos complejos y conllevan un alto riesgo de perder dinero rápidamente debido al apalancamiento.
74%
de inversores minoristas pierde dinero al operar CFDs con este proveedor.
Debes considerar si entiendes cómo funcionan los CFDs y si puedes permitirte asumir el alto riesgo de perder tu dinero.
74%
de los inversores minoristas pierde dinero cuando opera CFDs con este proveedor.
Invertir conlleva riesgos y no es adecuado para todos los inversores. Los CFDs son instrumentos complejos y conllevan un alto riesgo de perder dinero rápidamente debido al apalancamiento.
74%
de inversores minoristas pierde dinero al operar CFDs con este proveedor.
Debes considerar si entiendes cómo funcionan los CFDs y si puedes permitirte asumir el alto riesgo de perder tu dinero.
GE HealthCare Technologies
Abierto
SectorSanidad
77.95 2.61
Resumen
Variación precio
24h
Mínimo
76.87
Máximo
78.41
Ingresos | -88M 500M |
|---|---|
Ventas | 229M 5B |
P/B Media del Sector | 15.109 35.733 |
BPA | 1.06 |
Rentabilidad por dividendo | 0.14 |
Margen de beneficios | 9.988 |
Empleados | 53,000 |
EBITDA | -65M 874M |
Recomendaciones | Compra Fuerte |
|---|---|
Estimación a 12 Meses | +12.9% upside |
Rentabilidad por dividendo Media del Sector | 0.14% 3.13% |
|---|---|
Próximas Ganancias | 29 oct 2025 |
Fecha Próximo Dividendo | 14 nov 2025 |
Capitalización Mercado | -1.9B 34B |
|---|---|
Apertura anterior | 75.34 |
Cierre anterior | 77.95 |
Noticias sobre sentimiento de mercado
By Acuity
50%
50%
173 / 371 Clasificación en Healthcare
GE HealthCare Technologies Gráfico
Resultados pasados no son un indicador fiable de resultados futuros.
Noticias Relacionadas
Comparación entre iguales
Cambio de precio
GE HealthCare Technologies previsión
Precio Objetivo
By TipRanks
12.9% repunte
Estimación a 12 Meses
Media 85.5 USD 12.9%
Máximo 93 USD
Mínimo 74 USD
De acuerdo con 8 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para GE HealthCare Technologies Dist en los últimos 3 meses.
Sentimiento
By Acuity
173 / 371 Clasificación en Sanidad
Noticias sobre sentimiento de mercado
Neutral
Volatilidad
Por debajo de la media
Volumen de Noticias (RCV)
Por debajo de la media
Finanzas
Gastos de venta y administración
Gastos operativos
Beneficio antes de impuestos
Ventas
Coste de ventas
Beneficio bruto de ventas
Gasto por intereses de deuda
EBITDA
Beneficio operativo
$
Acerca de GE HealthCare Technologies
GE HealthCare Technologies Inc. engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics. The Imaging segment offers molecular imaging, computed tomography (CT) scanning, magnetic resonance (MR) imaging, image-guided therapy, X-ray systems, and women's health products. The Ultrasound segment provides medical devices and solutions for screening, diagnosis, treatment, and monitoring of certain diseases in clinical areas, such as radiology and primary care, women's health, cardiovascular, and point of care and handheld ultrasound solutions, as well as surgical visualization and guidance products. The Patient Care Solutions segment provides medical devices, consumables, services, and digital solutions. Its portfolio includes patient monitoring solutions, anesthesia delivery and respiratory care products, electrocardiogram solutions, maternal infant care products, and consumables and services. The Pharmaceutical Diagnostics supplies diagnostic agents, including CT, angiography and X-ray, MR, single-photon emission computed tomography, positron emission tomography, and ultrasound to the radiology and nuclear medicine industry. The segment also provides contrast media pharmaceuticals that are administered to a patient prior to certain diagnostic scans to increase the visibility of tissues or structures during imaging exams; and molecular imaging agents or radiopharmaceuticals, which are molecular tracers labeled with radioisotopes. It has an AI collaboration with Mass General Brigham. The company was formerly known as GE Healthcare Holding LLC and changed its name to GE HealthCare Technologies Inc. in December 2022. The company was incorporated in 2022 and is headquartered in Chicago, Illinois.
Live chat